Eye-Tracking app could spot MS earlier

NCT ID NCT05776511

Recruiting now Diagnosis Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a tablet-based eye-tracking app (eVOG) can detect subtle eye movement problems in people with brain MRI abnormalities (white matter lesions). The goal is to see if these eye movement patterns can help diagnose multiple sclerosis or related conditions. Researchers will compare results from 150 participants and healthy controls to determine the app's diagnostic value.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: eVOG (mobile video oculography app on a tablet)
What this could lead to: If successful, this could provide a simple, non-invasive tool to help doctors diagnose multiple sclerosis earlier and more accurately.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The eye-tracking method may not reliably distinguish between different causes of white matter lesions, and results may not apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS RADIOLOGICALLY ISOLATED SYNDROME WHITE MATTER LESIONS

Contacts and locations

Locations

Nice University Hospital
RECRUITING

Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.